UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Cancer research (Chicago, Ill.), 2012-03, Vol.72 (6), p.1494-1503

2012

Volltextzugriff (PDF)

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

eLife, 2016-07, Vol.5

2016

Volltextzugriff (PDF)

Discovery of Dual Inducible/Neuronal Nitric Oxide Synthase (iNOS/nNOS) Inhibitor Development Candidate 4-((2-Cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) Part 2: Identification of a Novel, Potent, and Selective Series of Benzimidazole-Quinolinone iNOS/nNOS Dimerization Inhibitors That Are Orally Active in Pain Models

Journal of medicinal chemistry, 2010-11, Vol.53 (21), p.7739-7755

2010

Volltextzugriff (PDF)

Six-Membered Ring Chelate Complexes of Ru(II): Structural and Photophysical Effects

Inorganic chemistry, 2007-11, Vol.46 (24), p.10354-10364

2007

Volltextzugriff (PDF)

Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

Synapse (New York, N.Y.), 2005-06, Vol.56 (4), p.205-216

2005

Volltextzugriff (PDF)

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

Molecular cancer therapeutics, 2008-05, Vol.7 (5), p.1054-1065

2008

Volltextzugriff (PDF)

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

eLife, 2019-01, Vol.8

2019

Volltextzugriff (PDF)

Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site

The Journal of pharmacology and experimental therapeutics, 2008-07, Vol.326 (1), p.240-251

2008

Volltextzugriff (PDF)

Identification of KD5170 : A novel mercaptoketone-based histone deacetylase inhibitor

Bioorganic & medicinal chemistry, 2008-12, Vol.18 (23), p.6093-6096

2008

Volltextzugriff (PDF)

Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts

Journal of medicinal chemistry, 2015-06, Vol.58 (12), p.4888-4904

2015

Volltextzugriff (PDF)

Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models

Journal of medicinal chemistry, 2009-05, Vol.52 (9), p.3047-3062

2009

Volltextzugriff (PDF)

Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer

Journal of medicinal chemistry, 2018-09, Vol.61 (17), p.7917-7928

2018

Volltextzugriff (PDF)

Maximizing ER‑α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927

ACS medicinal chemistry letters, 2019-01, Vol.10 (1), p.50-55

2019

Volltextzugriff (PDF)

KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization

Molecular pharmacology, 2009-07, Vol.76 (1), p.153-162

2009

Volltextzugriff (PDF)

Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft

Bioorganic & medicinal chemistry letters, 2015-11, Vol.25 (22), p.5163-5167

2015

Volltextzugriff (PDF)

Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft

Bioorganic & medicinal chemistry letters, 2019-02, Vol.29 (3), p.367-372

2019

Volltextzugriff (PDF)

Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (2), p.1237-1241

2012

Volltextzugriff (PDF)

Abstract 1648: Discovery and evolution of orally bioavailable selective estrogen receptor degraders for ER+ breast cancer: From GDC-0810 to GDC-0927

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1648-1648

2018

Volltextzugriff (PDF)

α-Mercaptoketone based histone deacetylase inhibitors

Bioorganic & medicinal chemistry, 2008-12, Vol.18 (24), p.6482-6485

2008

Volltextzugriff (PDF)

Abstract C16: Targeting AR in castration-resistant prostate cancer: Development of ARN-509 and second-generation antiandrogen resistance models

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4_Supplement), p.C16-C16

2012

Volltextzugriff (PDF)

ARN-509: a novel anti-androgen for prostate cancer treatment

Cancer research (Chicago, Ill.), 2012-01, Vol.72 (6), p.1494-1503

2012

Volltextzugriff (PDF)

Abstract A133: A novel class of selective estrogen receptor degraders regresses tumors in preclinical models of endocrine-resistant breast cancer

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A133-A133

2011

Volltextzugriff (PDF)

A luminescent Pt(II) complex with a terpyridine-like ligand involving a six-membered chelate ring

Dalton transactions : an international journal of inorganic chemistry, 2005-01 (2), p.354-358

2005

Volltextzugriff (PDF)

Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia

Bioorganic & medicinal chemistry letters, 2005-09, Vol.15 (18), p.4068-4072

2005

Volltextzugriff (PDF)

Cyclometalated Complexes of Ru(II) with 2-Aryl Derivatives of Quinoline and 1,10-Phenanthroline

Inorganic chemistry, 2001-11, Vol.40 (23), p.5851-5859

2001

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Six-Membered Ring Chelate Complexes of Ru(II): Structural and Photophysical Effects

Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site

Identification of KD5170 : A novel mercaptoketone-based histone deacetylase inhibitor

Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts

Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models

Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer

Maximizing ER‑α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927

KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization

Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft

Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft

Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors

Abstract 1648: Discovery and evolution of orally bioavailable selective estrogen receptor degraders for ER+ breast cancer: From GDC-0810 to GDC-0927

α-Mercaptoketone based histone deacetylase inhibitors

Abstract C16: Targeting AR in castration-resistant prostate cancer: Development of ARN-509 and second-generation antiandrogen resistance models

ARN-509: a novel anti-androgen for prostate cancer treatment

Abstract A133: A novel class of selective estrogen receptor degraders regresses tumors in preclinical models of endocrine-resistant breast cancer

A luminescent Pt(II) complex with a terpyridine-like ligand involving a six-membered chelate ring

Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia

Cyclometalated Complexes of Ru(II) with 2-Aryl Derivatives of Quinoline and 1,10-Phenanthroline

Suchergebnisse filtern